Latest Market News

Island Pharmaceuticals will host a webinar to discuss the FDA's feedback on the clinical development and regulatory approval of its antiviral drug Galidesivir, including key considerations under the FDA's Animal Rule and Priority Review Voucher eligibility.

Tombador Iron Limited reports a quarterly loss amid a strategic acquisition of GoviEx Uranium, signaling a pivot to uranium exploration and a rebrand to Atomic Eagle Limited.

Matsa Resources has officially commenced gold production at its Devon Pit Gold Mine, marking a significant step forward in its Lake Carey Gold Project. With maiden reserves confirmed and a robust option agreement in place with AngloGold Ashanti, the company is poised for growth amid ongoing exploration success.

Volt Group Limited is set to acquire Perth-based 4D Delta Pty Ltd for $7.25 million, adding a profitable digital asset inspection business to its portfolio. The acquisition is supported by a $4 million capital raise and aims to accelerate Volt’s growth in technology-enabled resource services.

DroneShield Limited has clarified the recent sharp decline in its share price, attributing the market movement to disclosed director share disposals rather than any undisclosed material information.

Resolution Minerals has clarified its compliance with ASX disclosure rules following a $2 million placement to Tribeca Investment Partners, confirming the transaction's material impact on its share price.

Cauldron Energy’s 2025 drilling campaign at Manyingee South has intersected significant high-grade uranium mineralisation, expanding the deposit’s footprint and reinforcing the Yanrey Project’s potential amid rising global uranium demand.

EBOS Group Limited has updated its Dividend Reinvestment Plan rules, offering shareholders new ways to reinvest dividends into additional shares. The changes, effective immediately, provide greater flexibility and maintain board discretion over share issuance terms.

City Chic Collective has reversed its fortunes with a $15 million EBITDA turnaround in FY25, driven by strategic restructuring and strong ANZ growth. The company eyes a debt-free 2025 close and cash flow positivity in FY26 amid cautious optimism for US market expansion.

Resonance Health has revealed ambitious growth plans at its 2025 AGM, projecting revenue to nearly quadruple by FY26 while maintaining positive EBITDA guidance. The company is broadening its global footprint and diversifying its clinical trial services across multiple therapeutic areas.

Shaver Shop Group Limited reported a record gross margin of 45.5% and EBIT growth of 2.4% in FY25, alongside a strong fully franked dividend. The 2025 AGM saw shareholder approval of key governance items including executive incentives.

Shaver Shop Group Limited reported steady sales of $219 million for FY25, with a notable 2.1% rise in gross profit driven by its private brand Transform-U. The company’s strategic focus on exclusive products and store network optimization sets a positive tone for 2026.